AML1/ETO upregulates fatty acid metabolism to induce venetoclax resistance in acute myeloid leukemia via activation of c-myc/SCD1 pathway

Venclexta (venetoclax) - Roche, AbbVie

Synribo (omacetaxine mepesuccinate) - Teva

azacitidine - Generic mfg.

Zhao Yin 1; Zurong Yao 1; Dandan Chen 1; Qifa Liu 1,2; Baohong Ping 1; Guopan Yu 1,3

Dec 5, 2025